Clinical Trials on Recalcitrant Alopecia Universalis

Total 504 results

Siriraj Hospital

Completed

The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis

Recalcitrant Alopecia Totalis | Recalcitrant Alopecia Universalis

Thailand
Aclaris Therapeutics, Inc.

Completed

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

Alopecia Totalis (AT) | Alopecia Universalis (AU)

United States
Yale University

Completed

Tofacitnib for the Treatment of Alopecia Areata and Variants

Alopecia Areata (AA) | Alopecia Totalis (AT) | Alopecia Universalis (AU)

United States
Throne Biotechnologies Inc.

Recruiting

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

United States
Jinnah Hospital

Completed

Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

Pakistan
Yale University

Completed

Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

United States
Equillium

Withdrawn

Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata

Alopecia Areata | Alopecia Totalis | Alopecia Universalis
Lindsey Bordone

Withdrawn

Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata

Alopecia Areata | Alopecia Totalis | Alopecia Universalis
Aclaris Therapeutics, Inc.

Completed

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis

Alopecia

United States
Aclaris Therapeutics, Inc.

Completed

Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

United States
Stanford University

Completed

Tofacitinib for the Treatment of Alopecia Areata and Its Variants

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

United States
King Saud University
Saudi Society of Dermatology and Dermatologic surgery

Completed

Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata

Alopecia Totalis | Alopecia Universalis | Ophiasic Alopecia

Saudi Arabia
Equillium
Equillium AUS Pty Ltd

Active, not recruiting

Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata

Alopecia | Alopecia Areata | Alopecia Totalis | Alopecia Universalis

Australia, New Zealand
Aclaris Therapeutics, Inc.

Terminated

ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

Alopecia Areata | Alopecia Totalis | Alopecia Universalis

United States
Julian M. Mackay-Wiggan

Withdrawn

Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis

Alopecia Totalis/Universalis
M.D. Anderson Cancer Center
National Alopecia Areata Foundation

Active, not recruiting

Alopecia Areata Registry (NAAR)

Alopecia Areata | Alopecia Totalis | Alopecia Universalis | Autoimmune Hair Loss | Alopecia Partialis

United States
Erasmus Medical Center

Recruiting

Systemic Treatments for Alopecia Areata Registry (STA2R)

Autoimmune Diseases | Alopecia | Alopecia Areata | Hair Diseases | Alopecia Totalis | Alopecia Universalis | Hair Loss | Alopecia Drugs

Netherlands
Novadip Biosciences

Active, not recruiting

Prospective Study in Adults Evaluating Safety & Efficacy of NVD003 for Bone Reconstruction to Treat Lower Limb Nonunion

Recalcitrant Lower Limb Nonunion

Luxembourg, Belgium, Switzerland
African Population and Health Research Center
Amsterdam Institute for Global Health and Development; PharmAccess

Unknown

Enhancing Universal Health Coverage and Maternal, Newborn and Child Health in Kenya Through Digital Innovations (UHC)

Universal Health Coverage
Cairo University

Not yet recruiting

HEMA-free Universal Adhesives for Restoring Non-carious Cervical Lesions

Universal Adhesive
Yale University

Completed

Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling

Fibrosing Alopecia | Frontal Fibrosing Alopecia | Central Centrifugal Cicatricial Alopecia

United States
Cairo University

Not yet recruiting

Clinical Performance of Self-cured Universal Adhesive for Restoring Cervical Lesions in Geriatric Patients

Universal Adhesive
Northern California Retina Vitreous Associates
Genentech, Inc.

Completed

Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept. (RESCUE)

Recalcitrant Wet Age-related Macular Degeneration

United States
Wake Forest University Health Sciences
The Skin of Color Society

Recruiting

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study (CCCA)

Central Centrifugal Cicatricial Alopecia (CCCA)

United States
University of Florida

Withdrawn

The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia

Female Androgenetic Alopecia

United States
Wake Forest University Health Sciences

Recruiting

A Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Central Centrifugal Cicatricial Alopecia

United States
Icahn School of Medicine at Mount Sinai

Completed

Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA)

Central Centrifugal Cicatricial Alopecia

United States
Wake Forest University Health Sciences

Recruiting

A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

Central Centrifugal Cicatricial Alopecia

United States
Wake Forest University Health Sciences

Withdrawn

Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA) (CCCA)

Central Centrifugal Cicatricial Alopecia

United States
Western Kentucky University

Recruiting

Multi-Tiered Systems of Support for Teacher Training in Classroom Management

Universal Behavioral Supports | Teacher Training

United States
Northwestern University

Completed

Barriers to Care and QOL for CCCA Patients

Central Centrifugal Cicatricial Alopecia | Scarring Alopecia | Central Centrifugal Scarring Alopecia

United States
King Edward Medical University

Completed

Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia (AGA)

Combination of SVF and PRP for Androgenetic Alopecia

Pakistan
Suzhou Kintor Pharmaceutical Inc,

Completed

Phase II Study Evaluating the Efficacy and Safety of KX-826

Androgenetic Alopecia (AGA)

China
Montefiore Medical Center
Sciton

Recruiting

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

Androgenetic Alopecia | Scarring Alopecia

United States
Johns Hopkins University

Enrolling by invitation

Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis

Central Centrifugal Cicatricial Alopecia (CCCA)

United States
University of Minnesota

Completed

Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia

Frontal Fibrosing Alopecia | Central Centrifugal Cicatricial Alopecia | Scarring Alopecia | Central Centrifugal Scarring Alopecia | Lichen Planopilaris

United States
Services Hospital, Lahore

Recruiting

Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia

Androgenetic Alopecia

Pakistan
Clinica Dermatologica Arbache ltda

Recruiting

MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine) (MMP)

Androgenic Alopecia

Brazil
Eli Lilly and Company

Recruiting

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata (BRAVE-AA-PEDS)

Skin Diseases | Pathological Conditions, Anatomical | Alopecia | Hypotrichosis | Hair Diseases | Areata Alopecia

United States, Taiwan, Japan, Spain, Korea, Republic of, Germany, France, Mexico, Canada, Poland, Australia, Hungary, Argentina
Chong Kun Dang Pharmaceutical

Recruiting

A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia

Androgenetic Alopecia

Korea, Republic of
Kasr El Aini Hospital

Recruiting

Fractional Laser Versus Radiofrequency in Androgenetic Alopecia

Androgenic Alopecia

Egypt
EMS

Recruiting

Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia

Androgenetic Alopecia

Brazil
Hope Medicine (Nanjing) Co., Ltd

Completed

To Evaluate the Safety, Tolerability and Efficacy in Male and Female With AGA Treated With HMI-115 Over a 24-week Treatment Period

Androgenetic Alopecia

Australia
Beauty Health
Callender Center for Clinical Research; ATS Clinical Research; Skin Surgery Medical... and other collaborators

Completed

Keravive by Hydrafacial for Scalp Health and Enhanced Hair Quality

Androgenic Alopecia

United States
Indonesia University

Active, not recruiting

Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia

Androgenetic Alopecia

Indonesia
Cairo University

Completed

Topical Cetirizine in Androgenetic Alopecia in Females

Androgenetic Alopecia

Egypt
University Hospitals Cleveland Medical Center
University of California, San Francisco; Kaiser Permanente

Completed

Microarray Analysis of Scalp Biopsies After Minoxidil Treatment

Androgenetic Alopecia

United States
Biosplice Therapeutics, Inc.

Completed

A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia

Androgenetic Alopecia

Turkey
Montefiore Medical Center

Withdrawn

Thulium Laser and KeraFactor for the Treatment of Androgenetic Alopecia

Androgenetic Alopecia

United States
Follicum AB
proDERM GmbH; Hair and Skin Institute, Charité, Berlin, Germany; Centroderm GmbH...

Completed

A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers

Androgenetic Alopecia

Germany

Clinical Trials on Recalcitrant Alopecia Universalis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations